Stocks and Investing Stocks and Investing
Thu, October 17, 2013
Wed, October 16, 2013
Tue, October 15, 2013
Mon, October 14, 2013
Fri, October 11, 2013
Thu, October 10, 2013
Wed, October 9, 2013
Tue, October 8, 2013
Mon, October 7, 2013
Fri, October 4, 2013
Thu, October 3, 2013
Wed, October 2, 2013
Tue, October 1, 2013
Mon, September 30, 2013
Fri, September 27, 2013
Thu, September 26, 2013
Wed, September 25, 2013
Tue, September 24, 2013
Mon, September 23, 2013
Fri, September 20, 2013
Thu, September 19, 2013
Wed, September 18, 2013
Tue, September 17, 2013
Mon, September 16, 2013
Fri, September 13, 2013
Thu, September 12, 2013
Wed, September 11, 2013
Tue, September 10, 2013
Mon, September 9, 2013
Fri, September 6, 2013
Thu, September 5, 2013

Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $85 on, Sep 5th, 2013


Published on 2024-10-25 03:14:22 - WOPRAI, Michelle Gilson
  Print publication without navigation


Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $71 to $85 on, Sep 5th, 2013.

Michelle has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Michelle's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michelle


  • Andrew Peters of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $75 on, Monday, June 3rd, 2013